Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$372.0 - $424.34 $1.79 Million - $2.04 Million
-4,816 Reduced 25.95%
13,740 $5.66 Million
Q1 2024

Apr 12, 2024

SELL
$284.87 - $413.31 $990,492 - $1.44 Million
-3,477 Reduced 15.78%
18,556 $7.5 Million
Q4 2023

Feb 13, 2024

BUY
$227.52 - $312.68 $287,357 - $394,914
1,263 Added 6.08%
22,033 $6.75 Million
Q3 2023

Nov 15, 2023

SELL
$233.98 - $281.67 $32,757 - $39,433
-140 Reduced 0.67%
20,770 $5.03 Million
Q2 2023

Aug 16, 2023

BUY
$187.26 - $240.17 $2,247 - $2,882
12 Added 0.06%
20,910 $5.02 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $13,944 - $19,161
-80 Reduced 0.38%
20,898 $3.93 Million
Q4 2022

Jan 25, 2023

SELL
$153.06 - $226.57 $603,362 - $893,138
-3,942 Reduced 15.82%
20,978 $4.46 Million
Q3 2022

Nov 08, 2022

BUY
$145.13 - $182.49 $117,119 - $147,269
807 Added 3.35%
24,920 $3.92 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $499,577 - $644,731
3,837 Added 18.92%
24,113 $3.61 Million
Q1 2022

May 18, 2022

SELL
$138.87 - $214.31 $14,442 - $22,288
-104 Reduced 0.51%
20,276 $3.32 Million
Q4 2021

Jan 20, 2022

SELL
$182.74 - $227.9 $1,461 - $1,823
-8 Reduced 0.04%
20,380 $4.44 Million
Q3 2021

Nov 10, 2021

SELL
$170.18 - $198.21 $925,949 - $1.08 Million
-5,441 Reduced 21.07%
20,388 $3.86 Million
Q2 2021

Aug 11, 2021

SELL
$158.62 - $194.3 $140,378 - $171,955
-885 Reduced 3.31%
25,829 $4.56 Million
Q1 2021

Apr 28, 2021

SELL
$132.02 - $168.26 $35,645 - $45,430
-270 Reduced 1.0%
26,714 $4.38 Million
Q4 2020

Feb 12, 2021

BUY
$109.38 - $149.19 $599,839 - $818,157
5,484 Added 25.51%
26,984 $3.76 Million
Q3 2020

Nov 16, 2020

SELL
$92.95 - $130.61 $193,336 - $271,668
-2,080 Reduced 8.82%
21,500 $2.4 Million
Q2 2020

Jul 15, 2020

SELL
$68.08 - $95.68 $251,896 - $354,016
-3,700 Reduced 13.56%
23,580 $2.19 Million
Q1 2020

May 11, 2020

BUY
$61.71 - $101.95 $1.68 Million - $2.78 Million
27,280 New
27,280 $2 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Bridge City Capital, LLC Portfolio

Follow Bridge City Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge City Capital, LLC with notifications on news.